Navigation Links
Digitek Medication Recalled Due to Risk of Digitalis Toxicity
Date:8/18/2009

EDISON, N.J.,, Aug. 18 /PRNewswire/ -- Digitek Medication: Digitek (digoxin tablets) is a widely-used medication used to treat various heart conditions, such as abnormal heart rhythms (atrial fibrillation & atrial flutter), and heart failure. Digitek is a powerful drug, which is so potent that even a slight increase in dosage can be toxic or fatal.

If you or a loved one has suffered digitalis toxicity or symptoms associated with digitalis toxicity as a result of taking Digitek, you should contact Eichen Levinson & Crutchlow (http://www.eichenlevinson.com/) to evaluate your claim. You may be entitled to compensation for medical expenses, loss of wages, and pain and suffering. Eichen's Digitek attorneys are able to handle and litigate Digitek cases no matter where you live

Digitek Recall: Following repeated Food and Drug Administration (FDA) criticisms of its manufacturing processes, the pharmaceutical company, Actavis Totowa issued a Class I nationwide drug recall for all lots of Digitek (digoxin) on the grounds that some tablets may contain twice the approved level of the active ingredient. A Class I recall is the most dangerous type of FDA recall. Even though the drugs are sold under different brand names, they are essentially the same product with the same active ingredient. Therefore, the recall pertains to Digitek tablets (all strengths) distributed by Mylan Pharmaceuticals and sold under the label "Bertek", as well as Digitek distributed by UDL Laboratories, Inc. and sold under the label "UDL".

Digitalis Toxicity Signs & Symptoms may include the following:

  • Visual changes, for example
    • Halos or rings of light around objects
    • Seeing lights or bright spots
    • Changes in color perception
    • Blind spots in vision
    • Blurred vision
  • Confusion
  • Loss of appetite
  • Nausea, vomiting, diarrhea
  • Palpitations
  • Irregular Pulse
  • Decreased urine output
  • Excessive nighttime urination
  • Overall Swelling
  • Decreased consciousness
  • Difficulty breathing when lying down

To evaluate your Digitek claim, contact Eichen Levinson & Crutchlow, with offices located in Edison, New Jersey and Toms River, New Jersey, provides award-winning legal services in the tri-state area and nationally in matters involving catastrophic personal injury, mass torts, medical malpractice, class actions, and consumer fraud litigation.

    Contact: Angela McKillop
    Amckillop@eichenlevinson.com
    EichenLevinson .com
    Tel: (732) 777-0100
    Fax: (732) 248-8273


'/>"/>
SOURCE Eichen Levinson & Crutchlow, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims
2. National Class Action Filed Against Manufacturer of Digitek(R) (Prescription Drug) in Federal Court in Michigan
3. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
4. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
5. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
6. Manic phase of bipolar disorder benefits from breast cancer medication
7. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
8. Mayo Clinic study indicates medication for ADHD may help student outcomes
9. Diet and medications may assist prevention of prostate cancer
10. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
11. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: